Eye Pathology pp 547-731 | Cite as

The Orbit, Including the Lacrimal Gland and Lacrimal Drainage System

  • Robert M. VerdijkEmail author
  • Irene Pecorella
  • Cornelia M. Mooy


This chapter describes the diseases of the orbit, lacrimal gland, and the lacrimal drainage system. The embryology and anatomy of these structures is described shortly. All disease processes are discussed subsequently: congenital abnormalities, inflammation and infection, degenerations, and neoplasms. In order to prevent doublures, certain disease processes and diseases are described in detail as orbital diseases which may be subsequently referred to in the paragraphs of the lacrimal gland and drainage system.



  1. 1.
    Barishak YR. Embryology of the eye and its adnexae. 2, revised edth ed. Freiburg: Karger; 2001. p. 132.Google Scholar
  2. 2.
    Jones KL, Higginbottom MC, Smith DW. Determining role of the optic vesicle in orbital and periocular development and placement. Pediatr Res. 1980;14(5):703–8.PubMedGoogle Scholar
  3. 3.
    de Haan AB, et al. The prenatal development of the human orbit. Strabismus. 2006;14(1):51–6.PubMedGoogle Scholar
  4. 4.
    Johnston MC, et al. Origins of avian ocular and periocular tissues. Exp Eye Res. 1979;29(1):27–43.PubMedGoogle Scholar
  5. 5.
    Le Lievre CS, Le Douarin NM. Mesenchymal derivatives of the neural crest: analysis of chimaeric quail and chick embryos. J Embryol Exp Morph. 1975;34(1):125–54.PubMedGoogle Scholar
  6. 6.
    Johnston MC, Bhakdinaronk A, Reid YC. An expanded role of the neural crest in oral and pharyngeal development. Symp Oral Sens Percept. 1973;4:37–52.PubMedGoogle Scholar
  7. 7.
    Johnston MC. A radioautographic study of the migration and fate of cranial neural crest cells in the chick embryo. Anat Rec. 1966;156(2):143–55.PubMedGoogle Scholar
  8. 8.
    Osanai H, et al. Human orbital muscle: a new point of view from the fetal development of extraocular connective tissues. Invest Ophthalmol Vis Sci. 2010;52(3):1501–6.Google Scholar
  9. 9.
    Fries PD, Katowitz JA. Congenital craniofacial anomalies of ophthalmic importance. Surv Ophthalmol. 1990;35(2):87–119.PubMedGoogle Scholar
  10. 10.
    Koornneef L. The development of the connective tissue in the human orbit. Acta Morph Neerl Scand. 1976;14(4):263–90.Google Scholar
  11. 11.
    Koornneef L. Orbital septa: anatomy and function. Ophthalmology. 1979;86(5):876–80.PubMedGoogle Scholar
  12. 12.
    Koornneef L. New insights in the human orbital connective tissue. Result of a new anatomical approach. Arch Ophthalmol. 1977;95(7):1269–73.PubMedGoogle Scholar
  13. 13.
    Koornneef L. Details of the orbital connective tissue system in the adult. Acta Morph Neerlandica Scand. 1977;15(1):1–34.Google Scholar
  14. 14.
    Koornneef L. Eyelid and orbital fascial attachments and their clinical significance. Eye (Lond). 1988;2(Pt 2):130–4.Google Scholar
  15. 15.
    Henderson JW, et al. Orbital cysts. In: Henderson JW, editor. Orbital tumors. Philadelphia: W.B. Saunders; 1973. p. 86–123.Google Scholar
  16. 16.
    Shields JA, Shields CL. Orbital cysts of childhood–classification, clinical features, and management. Surv Ophthalmol. 2004;49(3):281–99.PubMedGoogle Scholar
  17. 17.
    West JA, Drewe RH, McNab AA. Atypical choristomatous cysts of the orbit. Aust N Z J Ophthalmol. 1997;25(2):117–23.PubMedGoogle Scholar
  18. 18.
    von Domarus H. A lacrimal gland cyst in the orbit. J Craniomaxillofac Surg. 1987;15(2):106–9.Google Scholar
  19. 19.
    Suh MH, et al. Osseous choristoma of an extraocular muscle. J AAPOS. 2008;12(1):83–4.PubMedGoogle Scholar
  20. 20.
    Iliff WJ, Green WR. Orbital tumors in children. In: Jakobiec FA, editor. Ocular and adnexal tumors. Birmingham: Aesculapium Publishing Company; 1978. p. 669–84.Google Scholar
  21. 21.
    Moon JH, et al. Bilateral ocular osseous choristomas. Pediatr Radiol. 2005;35(11):1145–6.PubMedGoogle Scholar
  22. 22.
    Wolter JR, Roosenberg RJ. Ectopic lymph node of the orbit simulating a lacrimal gland tumor. Am J Ophthalmol. 1977;83(6):908–14.PubMedGoogle Scholar
  23. 23.
    Wang H, et al. Ectopic pituitary adenoma in the spheno-orbital region. J Neuroophthalmol. 2010;30(2):135–7.PubMedGoogle Scholar
  24. 24.
    Rootman J. Diseases of the orbit: a multidisciplinary approach. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 579.Google Scholar
  25. 25.
    Karcioğlu ZA. Orbital tumors: diagnosis and treatment. 1st ed. New York: Springer; 2005.Google Scholar
  26. 26.
    Weill A, et al. Embolization of an orbital varix after surgical exposure. AJNR Am J Neuroradiol. 1998;19(5):921–3.PubMedGoogle Scholar
  27. 27.
    Porges Y, et al. Hereditary microphthalmia with colobomatous cyst. Am J Ophthalmol. 1992;114(1):30–4.PubMedGoogle Scholar
  28. 28.
    Mihora LD, et al. Ectopic orbital brain diagnosed 20 years after symptomatic presentation. Orbit. 2009;28(2–3):185–7.PubMedGoogle Scholar
  29. 29.
    Islam N, et al. Orbital varices, cranial defects, and encephaloceles: an unrecognized association. Ophthalmology. 2004;111(6):1244–7.PubMedGoogle Scholar
  30. 30.
    Chan JK. Inflammatory pseudotumor: a family of lesions of diverse nature and aetiologies. Adv Anat Pathol. 1996;3(3):156–71.Google Scholar
  31. 31.
    Manschot WA. Coenurus infestation of eye and orbit. Arch Ophthalmol. 1976;94(6):961–4.PubMedGoogle Scholar
  32. 32.
    Brihaye M, et al. Hydatid cyst of the orbit. Bull Soc Belge Ophtalmol. 1967;146:317–28.PubMedGoogle Scholar
  33. 33.
    Pushker N, et al. Ocular and orbital cysticercosis. Acta Ophthalmol Scand. 2001;79(4):408–13.PubMedGoogle Scholar
  34. 34.
    Manschot WA. Intraocular cysticercus. Arch Ophthalmol. 1968;80(6):772–4.PubMedGoogle Scholar
  35. 35.
    Orihel TC, Eberhard ML. Zoonotic filariasis. Clin Microbiol Rev. 1998;11(2):366–81.PubMedCentralPubMedGoogle Scholar
  36. 36.
    McNab AA, Wright JE. Orbitofrontal cholesterol granuloma. Ophthalmology. 1990;97(1):28–32.PubMedGoogle Scholar
  37. 37.
    Fukuta K, Jackson IT. Epidermoid cyst and cholesterol granuloma of the orbit. Br J Plast Surg. 1990;43(5):521–7.PubMedGoogle Scholar
  38. 38.
    Donker DL, et al. Blepharoptosis and upper eyelid swelling due to lipogranulomatous inflammation caused by silicone oil. Am J Ophthalmol. 2005;140(5):934–6.PubMedGoogle Scholar
  39. 39.
    Witschel H, Geiger K. Paraffin induced sclerosing lipogranuloma of eyelids and anterior orbit following endonasal sinus surgery. Br J Ophthalmol. 1994;78(1):61–5.PubMedCentralPubMedGoogle Scholar
  40. 40.
    van Steensel L, et al. Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves’ ophthalmopathy. J Clin Endocrinol Metab. 2012;97(3):E400–8.PubMedGoogle Scholar
  41. 41.
    Soeters MR, et al. Optimal management of Graves orbitopathy: a multidisciplinary approach. Neth J Med. 2011;69(7):302–8.PubMedGoogle Scholar
  42. 42.
    LeBedis CA, Sakai O. Nontraumatic orbital conditions: diagnosis with CT and MR imaging in the emergent setting. Radiographics. 2008;28(6):1741–53.PubMedGoogle Scholar
  43. 43.
    Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003;121(4):491–9.PubMedGoogle Scholar
  44. 44.
    Yuen SJ, Rubin PA. Idiopathic orbital inflammation: ocular mechanisms and clinicopathology. Ophthalmol Clin N Am. 2002;15(1):121–6.Google Scholar
  45. 45.
    Belanger C, et al. Inflammatory disorders of the orbit in childhood: a case series. Am J Ophthalmol. 2010;150(4):460–3.PubMedGoogle Scholar
  46. 46.
    Swamy BN, et al. Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol. 2007;91(12):1667–70.PubMedCentralPubMedGoogle Scholar
  47. 47.
    Rootman J, et al. Idiopathic sclerosing inflammation of the orbit. A distinct clinicopathologic entity. Ophthalmology. 1994;101(3):570–84.PubMedGoogle Scholar
  48. 48.
    Divatia M, Kim SA, Ro JY. IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease. Yonsei Med J. 2012;53(1):15–34.PubMedCentralPubMedGoogle Scholar
  49. 49.
    Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol. 2010;17(5):303–32.PubMedGoogle Scholar
  50. 50.
    Takahira M, et al. IgG4-related chronic sclerosing dacryoadenitis. Arch Ophthalmol. 2007;125(11):1575–8.PubMedGoogle Scholar
  51. 51.
    Wallace ZS, et al. IgG4-related systemic disease as a cause of “idiopathic” orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol. 2012;57(1):26–33.PubMedGoogle Scholar
  52. 52.
    Matsui S, et al. Respiratory involvement in IgG4-related Mikulicz’s disease. Mod Rheumatol. 2011;22(1):31–9.PubMedGoogle Scholar
  53. 53.
    Plaza JA, et al. Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease. Arch Ophthalmol. 2011;129(4):421–8.PubMedGoogle Scholar
  54. 54.
    Go H, et al. Ocular adnexal IgG4-related disease: comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions. Histopathology. 2012;60(2):296–312.PubMedGoogle Scholar
  55. 55.
    Andrew N, Kearney D, Selva D. IgG4-related orbital disease: a meta-analysis and review. Acta Ophthalmol. 2013;91(8):694–700.PubMedGoogle Scholar
  56. 56.
    Singh K, Rajan KD, Eberhart C. Orbital necrobiotic xanthogranuloma associated with systemic IgG4 disease. Ocul Immunol Inflamm. 2010;18(5):373–8.PubMedGoogle Scholar
  57. 57.
    Mudhar HS, Bhatt R, Sandramouli S. Xanthogranulomatous variant of immunoglobulin G4 sclerosing disease presenting as ptosis, proptosis and eyelid skin plaques. Int Ophthalmol. 2011;31(3):245–8.PubMedGoogle Scholar
  58. 58.
    Kubota T, et al. Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells. J Clin Pathol. 2010;63(12):1059–65.PubMedCentralPubMedGoogle Scholar
  59. 59.
    Sivak-Callcott JA, et al. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol. 2006;90(5):602–8.PubMedCentralPubMedGoogle Scholar
  60. 60.
    Jaffe R, et al. Histiocytic and dendritic neoplasms. In: Swerdlow SH, editor. WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva: IARC; 2008. p. 354–5.Google Scholar
  61. 61.
    Verdijk RM, et al. Raised numbers of IgG4-positive plasma cells are a common histopathological finding in orbital xanthogranulomatous disease. Orbit. 2013; 33(1):17–22.Google Scholar
  62. 62.
    Jakobiec FA, et al. Periocular xanthogranulomas associated with severe adult-onset asthma. Trans Am Ophthalmol Soc. 1993;91:99–125; discussion 125–9.PubMedCentralPubMedGoogle Scholar
  63. 63.
    Ugurlu S, Bartley GB, Gibson LE. Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement. Am J Ophthalmol. 2000;129(5):651–7.PubMedGoogle Scholar
  64. 64.
    Johnson TE, et al. Extensive juvenile xanthogranuloma involving the orbit, sinuses, brain, and subtemporal fossa in a newborn. Ophthal Plast Reconstr Surg. 2010;26(2):133–4.PubMedGoogle Scholar
  65. 65.
    Betts DR, et al. Constitutional balanced chromosomal rearrangements and neoplasm in children. J Pediatr Hematol Oncol. 2001;23(9):582–4.PubMedGoogle Scholar
  66. 66.
    Woywodt A, Matteson EL. Wegener’s granulomatosis – probing the untold past of the man behind the eponym. Rheumatology (Oxford). 2006;45(10):1303–6.Google Scholar
  67. 67.
    Perry SR, Rootman J, White VA. The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology. 1997;104(4):683–94.PubMedGoogle Scholar
  68. 68.
    Perumal B, et al. Non-infectious orbital vasculitides. Eye (Lond). 2012;26(5):630–9.PubMedCentralGoogle Scholar
  69. 69.
    Ohsie LH, Murchison AP, Wojno TH. Lupus erythematosus profundus masquerading as idiopathic orbital inflammatory syndrome. Orbit. 2012;31(3):181–3.PubMedGoogle Scholar
  70. 70.
    Jordan N, et al. Dacryoadenitis and diffuse orbital inflammation: unusual first presentations of Churg-Strauss syndrome. Orbit. 2011;30(3):160–1.PubMedGoogle Scholar
  71. 71.
    Borruat FX, et al. Orbital infarction syndrome. Ophthalmology. 1993;100(4):562–8.PubMedGoogle Scholar
  72. 72.
    Demirci H, Christianson MD. Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30 cases. Am J Ophthalmol. 2011;151(6):1074–80.e1.PubMedGoogle Scholar
  73. 73.
    Messmer EP, et al. Amputation neuroma of the orbit. Report of two cases and review of the literature. Ophthalmology. 1984;91(11):1420–3.PubMedGoogle Scholar
  74. 74.
    Schick U, Hassler W. Treatment of deep vascular orbital malformations. Clin Neurol Neurosurg. 2009;111(10):801–7.PubMedGoogle Scholar
  75. 75.
    Knowles 2nd DM, et al. Amyloidosis of the orbit and adnexae. Surv Ophthalmol. 1975;19(6):367–84.PubMedGoogle Scholar
  76. 76.
    Murdoch IE, et al. Primary localised amyloidosis of the orbit. Br J Ophthalmol. 1996;80(12):1083–6.PubMedCentralPubMedGoogle Scholar
  77. 77.
    Goshe JM, et al. Myeloma-associated orbital amyloidosis. Orbit. 2010;29(5):274–7.PubMedGoogle Scholar
  78. 78.
    Connors LH, et al. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid. 2003;10(3):160–84.PubMedGoogle Scholar
  79. 79.
    Fletcher CD, Unni KK, Mertens F. Pathology and genetics of tumours of soft tissue and bone. In: Kleihues P, Sobin LH, editors. World Health Organization classification of tumours. Lyon: IARCPress; 2002.Google Scholar
  80. 80.
    DiNardo LJ, Wetmore RF, Potsic WP. Nodular fasciitis of the head and neck in children. A deceptive lesion. Arch Otolaryngol Head Neck Surg. 1991;117(9):1001–2.PubMedGoogle Scholar
  81. 81.
    Shields JA, et al. Orbital nodular fasciitis simulating a dermoid cyst in an 8-month-old child. Case report and review of the literature. Ophthal Plast Reconstr Surg. 2001;17(2):144–8.PubMedGoogle Scholar
  82. 82.
    Tolls RE, Mohr S, Spencer WH. Benign nodular fasciitis originating in Tenon’s capsule. Arch Ophthalmol. 1966;75(4):482–3.PubMedGoogle Scholar
  83. 83.
    Ferry AP, Sherman SE. Nodular fasciitis of the conjunctiva apparently originating in the fascia bulbi (Tenon’s capsule). Am J Ophthalmol. 1974;78(3):514–7.PubMedGoogle Scholar
  84. 84.
    Riffle JE, et al. Nodular fasciitis of the orbit: a case report and brief review of the literature. Case Rep Ophthalmol Med. 2011;2011:235956.PubMedCentralPubMedGoogle Scholar
  85. 85.
    Damasceno RW, et al. Nodular fasciitis of the eyelid and anterior orbit in children: case report and review of the literature. Ophthalmologe. 2009;106(9):829–31.PubMedGoogle Scholar
  86. 86.
    Weiss SW, Goldblum JR. Enzinger & Weiss’s soft tissue tumors. 5th ed. Philadelphia: Mosby; 2008.Google Scholar
  87. 87.
    Mynatt CJ, Feldman KA, Thompson LD. Orbital infantile myofibroma: a case report and clinicopathologic review of 24 cases from the literature. Head Neck Pathol. 2011;5(3):205–15.PubMedCentralPubMedGoogle Scholar
  88. 88.
    Gatibelza ME, et al. Isolated infantile myofibromatosis of the upper eyelid: uncommon localization and long-term results after surgical management. J Pediatr Surg. 2012;47(7):1457–9.PubMedGoogle Scholar
  89. 89.
    Bloom RI, et al. A case of congenital myofibroma of the orbit presenting at birth. Orbit. 2013;32(1):33–5.PubMedGoogle Scholar
  90. 90.
    Duffy MT, Harris M, Hornblass A. Infantile myofibromatosis of orbital bone. A case report with computed tomography, magnetic resonance imaging, and histologic findings. Ophthalmology. 1997;104(9):1471–4.PubMedGoogle Scholar
  91. 91.
    Calsina M, et al. Solitary orbital myofibroma: clinical, radiographic, and histopathologic findings. A report of two cases. Orbit. 2011;30(4):180–2.PubMedGoogle Scholar
  92. 92.
    De Wan J, Evens F, De Mey A. Eyelid tumour and juvenile hyaline fibromatosis. Br J Plast Surg. 2005;58(1):106–11.PubMedGoogle Scholar
  93. 93.
    Pushker N, et al. Infantile hemangiopericytoma of the orbit treated with primary chemotherapy. J Pediatr Ophthalmol Strabismus. 2012;49:e23–5.PubMedGoogle Scholar
  94. 94.
    Mentzel T, et al. Infantile hemangiopericytoma versus infantile myofibromatosis. Study of a series suggesting a continuous spectrum of infantile myofibroblastic lesions. Am J Surg Pathol. 1994;18(9):922–30.PubMedGoogle Scholar
  95. 95.
    Polito E, et al. Inflammatory myofibroblastic tumor of the orbit. Ophthalmologica. 2007;221(5):353–5.PubMedGoogle Scholar
  96. 96.
    Cessna MH, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol. 2002;15(9):931–8.PubMedGoogle Scholar
  97. 97.
    O’Malley DP, et al. Intraocular inflammatory myofibroblastic tumor with ALK overexpression. Arch Pathol Lab Med. 2004;128(1):e5–7.PubMedGoogle Scholar
  98. 98.
    Sa HS, et al. Inflammatory myofibroblastic tumor of the orbit presenting as a subconjunctival mass. Ophthal Plast Reconstr Surg. 2005;21(3):211–5.PubMedGoogle Scholar
  99. 99.
    Yamamoto H, et al. Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study. Am J Surg Pathol. 2009;33(9):1330–40.PubMedGoogle Scholar
  100. 100.
    Furusato E, et al. Orbital solitary fibrous tumor: encompassing terminology for hemangiopericytoma, giant cell angiofibroma, and fibrous histiocytoma of the orbit: reappraisal of 41 cases. Hum Pathol. 2010;42(1):120–8.PubMedGoogle Scholar
  101. 101.
    Bernardini FP, et al. Solitary fibrous tumor of the orbit: is it rare? Report of a case series and review of the literature. Ophthalmology. 2003;110(7):1442–8.PubMedGoogle Scholar
  102. 102.
    Font RL, Hidayat AA. Fibrous histiocytoma of the orbit. A clinicopathologic study of 150 cases. Hum Pathol. 1982;13(3):199–209.PubMedGoogle Scholar
  103. 103.
    Hidayat AA, et al. Myxomas and angiomyxomas of the orbit: a clinicopathologic study of 6 cases. Ophthalmology. 2007;114(5):1012–9.PubMedGoogle Scholar
  104. 104.
    Zhang Q, et al. Myxofibrosarcoma of the orbit: a clinicopathologic case report. Ophthal Plast Reconstr Surg. 2010;26(2):129–31.PubMedCentralPubMedGoogle Scholar
  105. 105.
    Russell H, et al. Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy. Pediatr Blood Cancer. 2009;53(1):23–7.PubMedGoogle Scholar
  106. 106.
    Bartley GB, et al. Spindle cell lipoma of the orbit. Am J Ophthalmol. 1985;100(4):605–9.PubMedGoogle Scholar
  107. 107.
    Johnson BL, Linn Jr JG. Spindle cell lipoma of the orbit. Arch Ophthalmol. 1979;97(1):133–4.PubMedGoogle Scholar
  108. 108.
    Daniel CS, et al. Pleomorphic lipoma of the orbit: a case series and review of literature. Ophthalmology. 2003;110(1):101–5.PubMedGoogle Scholar
  109. 109.
    Dutton JJ, Wright Jr JD. Intramuscular lipoma of the superior oblique muscle. Orbit. 2006;25(3):227–33.PubMedGoogle Scholar
  110. 110.
    Kim MH, et al. Fibrolipoma of the orbit. Ophthal Plast Reconstr Surg. 2011;27(1):e16–8.PubMedGoogle Scholar
  111. 111.
    Farah-Klibi F, et al. Lipomatous hemangiopericytoma (adipocytic variant of solitary fibrous tumor) of the orbit. A case report with review of the literature. Pathologica. 2006;98(6):645–8.PubMedGoogle Scholar
  112. 112.
    Jakobiec FA, et al. MDM2-positive atypical lipomatous neoplasm/well-differentiated liposarcoma versus spindle cell lipoma of the orbit. Ophthal Plast Reconstr Surg. 2010;26(6):413–5.PubMedGoogle Scholar
  113. 113.
    Madge SN, et al. Primary orbital liposarcoma. Ophthalmology. 2010;117(3):606–14.PubMedGoogle Scholar
  114. 114.
    Shinder R, et al. Primary orbital liposarcoma misdiagnosed as thyroid associated orbitopathy. Orbit. 2012;31(4):264–6.PubMedGoogle Scholar
  115. 115.
    Hannachi Sassi S, et al. Orbital metastasis of liposarcoma. J Fr Ophtalmol. 2007;30(9):e28.PubMedGoogle Scholar
  116. 116.
    Cai YC, et al. Primary liposarcoma of the orbit: a clinicopathologic study of seven cases. Ann Diagn Pathol. 2001;5(5):255–66.PubMedGoogle Scholar
  117. 117.
    Ebrahimi KB, Ren S, Green WR. Floretlike cells in in situ and prolapsed orbital fat. Ophthalmology. 2007;114(12):2345–9.PubMedGoogle Scholar
  118. 118.
    Thway K, et al. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am J Surg Pathol. 2012;36(3):462–9.PubMedGoogle Scholar
  119. 119.
    Arat YO, et al. Leiomyoma of the orbit and periocular region: a clinicopathologic study of four cases. Ophthal Plast Reconstr Surg. 2005;21(1):16–22.PubMedGoogle Scholar
  120. 120.
    Fernandes BF, et al. Orbital leiomyoma: histopathologic and immunohistochemical findings of a rare tumor. Ophthal Plast Reconstr Surg. 2009;25(1):59–61.PubMedGoogle Scholar
  121. 121.
    Gunduz K, et al. Orbital leiomyoma: report of a case and review of the literature. Surv Ophthalmol. 2004;49(2):237–42.PubMedGoogle Scholar
  122. 122.
    Chen J, Wei R, Ma X. Orbital metastasis of retroperitoneal leiomyosarcoma. Med Oncol. 2012;29(1):392–5.PubMedGoogle Scholar
  123. 123.
    Hou LC, Murphy MA, Tung GA. Primary orbital leiomyosarcoma: a case report with MRI findings. Am J Ophthalmol. 2003;135(3):408–10.PubMedGoogle Scholar
  124. 124.
    Klippenstein KA, Wesley RE, Glick AD. Orbital leiomyosarcoma after retinoblastoma. Ophthalmic Surg Lasers. 1999;30(7):579–83.PubMedGoogle Scholar
  125. 125.
    Li YP, et al. Rhabdomyoma of the orbit. J Pediatr Ophthalmol Strabismus. 2008;45(2):113–5.PubMedGoogle Scholar
  126. 126.
    Stout AP. Rhabdomyosarcoma of the skeletal muscles. Ann Surg. 1946;123(3):447–72.PubMedCentralGoogle Scholar
  127. 127.
    Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med. 1999;341(5):342–52.PubMedGoogle Scholar
  128. 128.
    Newton Jr WA, et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol. 1988;6(1):67–75.PubMedGoogle Scholar
  129. 129.
    Kodet R, et al. Orbital rhabdomyosarcomas and related tumors in childhood: relationship of morphology to prognosis–an Intergroup Rhabdomyosarcoma study. Med Pediatr Oncol. 1997;29(1):51–60.PubMedGoogle Scholar
  130. 130.
    Polito E, et al. A case of primary botryoid conjunctival rhabdomyosarcoma. Graefes Arch Clin Exp Ophthalmol. 2006;244(4):517–9.PubMedGoogle Scholar
  131. 131.
    Qualman SJ, et al. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol. 1998;1(6):550–61.PubMedGoogle Scholar
  132. 132.
    Chaves E. Pleomorphic rhabdomyosarcoma of the orbit. Presentation of a case. Rev Bras Oftalmol. 1967;26(1):73–82.PubMedGoogle Scholar
  133. 133.
    Furlong MA, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in children: four cases in the pediatric age group. Ann Diagn Pathol. 2001;5(4):199–206.PubMedGoogle Scholar
  134. 134.
    Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol. 2001;14(6):595–603.PubMedGoogle Scholar
  135. 135.
    Sullivan LM, Atkins KA, LeGallo RD. PAX immunoreactivity identifies alveolar rhabdomyosarcoma. Am J Surg Pathol. 2009;33(5):775–80.PubMedGoogle Scholar
  136. 136.
    Barr FG. Molecular genetics and pathogenesis of rhabdomyosarcoma. J Pediatr Hematol Oncol. 1997;19(6):483–91.PubMedGoogle Scholar
  137. 137.
    Sumegi J, et al. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosome Cancer. 2010;49(3):224–36.Google Scholar
  138. 138.
    Punyko JA, et al. Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation. Cancer. 2005;103(7):1475–83.PubMedGoogle Scholar
  139. 139.
    Ulivieri S, et al. Orbital glomangioma. Orbit. 2012;31(4):216–8.PubMedGoogle Scholar
  140. 140.
    Granter SR, Badizadegan K, Fletcher CD. Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am J Surg Pathol. 1998;22(5):513–25.PubMedGoogle Scholar
  141. 141.
    Rosca TI, et al. Vascular tumors in the orbit–capillary and cavernous hemangiomas. Ann Diagn Pathol. 2006;10(1):13–9.PubMedGoogle Scholar
  142. 142.
    Acocella A, Catelani C, Nardi P. Angiolymphoid hyperplasia with eosinophilia: a case report of orbital involvement. J Oral Maxillofac Surg. 2005;63(1):140–4.PubMedGoogle Scholar
  143. 143.
    Seregard S. Angiolymphoid hyperplasia with eosinophilia should not be confused with Kimura’s disease. Acta Ophthalmol Scand. 2001;79(1):91–3.PubMedGoogle Scholar
  144. 144.
    Lopes M, Duffau H, Fleuridas G. Primary spheno-orbital angiosarcoma: case report and review of the literature. Neurosurgery. 1999;44(2):405–7; discussion 407–8.PubMedGoogle Scholar
  145. 145.
    Lyon DB, Tang TT, Kidder TM. Epithelioid hemangioendothelioma of the orbital bones. Ophthalmology. 1992;99(12):1773–8.PubMedGoogle Scholar
  146. 146.
    Kivela T, Tarkkanen A. Orbital germ cell tumors revisited: a clinicopathological approach to classification. Surv Ophthalmol. 1994;38(6):541–54.PubMedGoogle Scholar
  147. 147.
    Oosterhuis JW, et al. Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. Int J Androl. 2007;30(4):256–63; discussion 263–4.PubMedGoogle Scholar
  148. 148.
    Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer. 1976;37(5):2359–72.PubMedGoogle Scholar
  149. 149.
    Gonzalez-Crussi F. Extragonadal teratomas. In: Hartmann WH, editor. Atlas of tumor pathology. 2nd ed. Washington, DC: Armed Forces Institute of Pathology; 1982.Google Scholar
  150. 150.
    Bernoulli R. On a primary teratoid sarcoma of the orbit. Opt Acta Lond. 1962;143:370–7.PubMedGoogle Scholar
  151. 151.
    Mahesh L, et al. Malignant teratoma of the orbit: a clinicopathological study of a case. Orbit. 2003;22(4):305–9.PubMedGoogle Scholar
  152. 152.
    Soares E, da Silva Lopes K, de Souza Andrade J. Orbital malignant teratoma. A case report. Orbit. 1983;2:235–42.Google Scholar
  153. 153.
    Garden JW, McManis JC. Congenital orbital-intracranial teratoma with subsequent malignancy: case report. Br J Ophthalmol. 1986;70(2):111–3.PubMedCentralPubMedGoogle Scholar
  154. 154.
    Ogun OA, et al. Congenital orbital teratoma: a case report and challenges of its management in a resource limited setting. Pan Afr Med J. 2012;12:3.PubMedCentralPubMedGoogle Scholar
  155. 155.
    O’Connor DM, Norris HJ. The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol. 1994;13(4):283–9.PubMedGoogle Scholar
  156. 156.
    Kiratli H, Erkan Balci K, Guler G. Primary orbital endodermal sinus tumor (yolk sac tumor). J AAPOS. 2008;12(6):623–5.PubMedGoogle Scholar
  157. 157.
    Margo CE, et al. Endodermal sinus tumor (yolk sac tumor) of the orbit. Ophthalmology. 1983;90(12):1426–32.PubMedGoogle Scholar
  158. 158.
    Perrini P, et al. Primary germinoma of the orbit. Neurosurgery. 2005;57(4):E813.PubMedGoogle Scholar
  159. 159.
    Altan-Yaycioglu R, Hintschich C. Clinical features and surgical management of orbitotemporal neurofibromatosis: a retrospective interventional case series. Orbit. 2010;29(5):232–8.PubMedGoogle Scholar
  160. 160.
    Singhal D, et al. Soft tissue management of orbitotemporal neurofibromatosis. J Craniofac Surg. 2013;24(1):269–72.PubMedGoogle Scholar
  161. 161.
    Spencer WH. Ophthalmic Pathology: An Atlas and Textbook, 4th edition. Philadelphia: W.B. Saunders; 1996. p. 125–155.Google Scholar
  162. 162.
    Pecorella I, Toth J, Lukats O. Ancient schwannoma of the orbit. Pathologica. 2012;104(4):182–4.PubMedGoogle Scholar
  163. 163.
    Dolman PJ, Rootman J, Dolman CL. Infiltrating orbital granular cell tumour: a case report and literature review. Br J Ophthalmol. 1987;71(1):47–53.PubMedCentralPubMedGoogle Scholar
  164. 164.
    Poyraz CE, Kiratli H, Soylemezoglu F. Granular cell tumor of the inferior rectus muscle. Korean J Ophthalmol. 2009;23(1):43–5.PubMedCentralPubMedGoogle Scholar
  165. 165.
    Romero-Rojas AE, Diaz-Perez JA, Lozano-Castillo A. Malignant peripheric nerve sheath tumor of the orbit: first description of orbital location in a patient with NF1. Neurocirugia (Astur). 2010;21(1):37–45.Google Scholar
  166. 166.
    Verdijk RM, et al. TP53 mutation analysis of malignant peripheral nerve sheath tumors. J Neuropathol Exp Neurol. 2010;69(1):16–26.PubMedGoogle Scholar
  167. 167.
    Overweg-Plandsoen WC, et al. Neurofibromatosis type 1: a survey of 195 patients. Ned Tijdschr Geneeskd. 1997;141(13):624–9.PubMedGoogle Scholar
  168. 168.
    Poyhonen M, Niemela S, Herva R. Risk of malignancy and death in neurofibromatosis. Arch Pathol Lab Med. 1997;121(2):139–43.PubMedGoogle Scholar
  169. 169.
    Rothenberg AB, et al. Neuroblastoma-remembering the three physicians who described it a century ago: James Homer Wright, William Pepper, and Robert Hutchison. Pediatr Radiol. 2009;39(2):155–60.PubMedGoogle Scholar
  170. 170.
    Okamatsu C, et al. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG. Pediatr Blood Cancer. 2009;53(4):563–9.PubMedCentralPubMedGoogle Scholar
  171. 171.
    Romero R, et al. Peripheral primitive neuroectodermal tumour of the orbit. Br J Ophthalmol. 2011;95(7):915–20.PubMedGoogle Scholar
  172. 172.
    Chokthaweesak W, et al. Primitive neuroectodermal tumor of the orbit in adults: a case series. Ophthal Plast Reconstr Surg. 2011;27(3):173–9.PubMedGoogle Scholar
  173. 173.
    Luo W, Xiao EH. CT, MRI and pathologic features of peripheral primitive neuroectodermal tumors: a report of eight cases with literature review. Ai Zheng. 2008;27(6):627–32.PubMedGoogle Scholar
  174. 174.
    Jedlicka P. Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions. Int J Clin Exp Pathol. 2010;3(4):338–47.PubMedCentralPubMedGoogle Scholar
  175. 175.
    Fratkin JD, et al. Wilms’ tumor metastatic to the orbit. JAMA. 1977;238(17):1841–2.PubMedGoogle Scholar
  176. 176.
    Kahwash SB, Qualman SJ. Cutaneous lymphoblastic lymphoma in children: report of six cases with precursor B-cell lineage. Pediatr Dev Pathol. 2002;5(1):45–53.PubMedGoogle Scholar
  177. 177.
    Randolph TR. Advances in acute lymphoblastic leukemia. Clin Lab Sci. 2004;17(4):235–45.PubMedGoogle Scholar
  178. 178.
    Gunduz K, Esmaeli B. Diagnosis and Management of Malignant Tumors of the Eyelid, Conjunctiva, and Orbit. Expert Rev Ophthalmol. 2008;3(1):63–75.Google Scholar
  179. 179.
    Hoyt WF, et al. Malignant optic glioma of adulthood. Brain. 1973;96(1):121–32.PubMedGoogle Scholar
  180. 180.
    Tari AS, Fard MA. Solitary orbital paget disease: a case report. Orbit. 2010;29(4):219–21.PubMedGoogle Scholar
  181. 181.
    Goldberg S, et al. Sarcomatous transformation of the orbit in a patient with Paget’s disease. Ophthalmology. 2000;107(8):1464–7.PubMedGoogle Scholar
  182. 182.
    Harris AE, et al. Giant cell tumor of the skull: a case report and review of the literature. Surg Neurol. 2004;61(3):274–7.PubMedGoogle Scholar
  183. 183.
    Goisis M, et al. Fibrous dysplasia of the orbital region: current clinical perspectives in ophthalmology and cranio-maxillofacial surgery. Ophthal Plast Reconstr Surg. 2006;22(5):383–7.PubMedGoogle Scholar
  184. 184.
    Selva D, et al. Primary bone tumors of the orbit. Surv Ophthalmol. 2004;49(3):328–42.PubMedGoogle Scholar
  185. 185.
    Chen CJ, et al. Malignant infantile osteopetrosis initially presenting with neonatal hypocalcemia: case report. Ann Hematol. 2003;82(1):64–7.PubMedGoogle Scholar
  186. 186.
    Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis. 2009;4:5.PubMedCentralPubMedGoogle Scholar
  187. 187.
    Kashkouli MB, et al. Primary endo-orbital osteoid osteoma. Orbit. 2008;27(3):211–3.PubMedGoogle Scholar
  188. 188.
    Dhermy P, Mazabraud A, Offret G. Tumors and pseudo-tumoral dysplasias of orbital bones. Arch Ophtalmol Paris. 1977;37(4):249–72.PubMedGoogle Scholar
  189. 189.
    Blodi FC. Pathology of orbital bones. The XXXII Edward Jackson Memorial lecture. Am J Ophthalmol. 1976;81(1):1–26.PubMedGoogle Scholar
  190. 190.
    McHugh JB, Mukherji SK, Lucas DR. Sino-orbital osteoma: a clinicopathologic study of 45 surgically treated cases with emphasis on tumors with osteoblastoma-like features. Arch Pathol Lab Med. 2009;133(10):1587–93.PubMedGoogle Scholar
  191. 191.
    Morita R, Shimada K, Kawakami S. Low-grade central osteosarcoma of the orbit. J Craniofac Surg. 2012;23(3):e178–80.PubMedGoogle Scholar
  192. 192.
    Fan JC, et al. Primary orbital extraskeletal osteosarcoma. Orbit. 2011;30(6):297–9.PubMedGoogle Scholar
  193. 193.
    Khouja N, et al. Mesenchymal extraskeletal chondrosarcoma of the orbit. Report of a case and review of the literature. Surg Neurol. 1999;52(1):50–3.PubMedGoogle Scholar
  194. 194.
    Daicker BC. Orbital chordoma. Ophthalmologica. 1978;176(4):236–9.PubMedGoogle Scholar
  195. 195.
    Vidor I, et al. Chordoma of the anterior cranial fossa and ethmoids with orbital involvement. Orbit. 2008;27(6):444–50.PubMedGoogle Scholar
  196. 196.
    Moshari A, et al. Ectopic chordoma with orbital invasion. Am J Ophthalmol. 2001;131(3):400–1.PubMedGoogle Scholar
  197. 197.
    Louis DN, et al. WHO classification of tumours of the central nervous system. In: Bosman FT, editor. World Health Organization classification of tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2007.Google Scholar
  198. 198.
    Walsh F. Meningiomas, primary within the orbit and optic canal. In: Neuro-ophthalmology, Symposium of the University of Miami and the Bascom Palmer Eye Institute. Halladale: Huffman Pub Co.; 1969.Google Scholar
  199. 199.
    Mawrin C, Perry A. Pathological classification and molecular genetics of meningiomas. J Neurooncol. 2010;99(3):379–91.PubMedGoogle Scholar
  200. 200.
    Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99(3):307–14.PubMedCentralPubMedGoogle Scholar
  201. 201.
    Jakobiec FA, McLean I, Font RL. Clinicopathologic characteristics of orbital lymphoid hyperplasia. Ophthalmology. 1979;86(5):948–66.PubMedGoogle Scholar
  202. 202.
    Knowles DM. Malignant lymphomas and lymphoid hyperplasias that occur in the ocular adnexa (orbit, conjunctiva and eyelids). In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1304.Google Scholar
  203. 203.
    McKelvie PA, et al. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Exp Ophthalmol. 2001;29(6):387–93.Google Scholar
  204. 204.
    Coupland SE, et al. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefes Arch Clin Exp Ophthalmol. 2004;242(2):130–45.PubMedGoogle Scholar
  205. 205.
    Stacy RC, et al. Unifocal and multifocal reactive lymphoid hyperplasia vs follicular lymphoma of the ocular adnexa. Am J Ophthalmol. 2010;150(3):412–26.e1.PubMedGoogle Scholar
  206. 206.
    Dogan A, et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol. 2000;24(6):846–52.PubMedGoogle Scholar
  207. 207.
    Andrew NH, Kearney D, Selva D. Intraorbital corticosteroid injection for orbital reactive lymphoid hyperplasia. Eye (Lond). 2013;27:561–3.Google Scholar
  208. 208.
    Ho HH, et al. Treatment of benign lymphoid hyperplasia of the orbit with rituximab. Ophthal Plast Reconstr Surg. 2010;26(1):11–3.PubMedGoogle Scholar
  209. 209.
    Johansen S, et al. Orbital space-occupying lesions in Denmark 1974–1997. Acta Ophthalmol Scand. 2000;78(5):547–52.PubMedGoogle Scholar
  210. 210.
    Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery lecture, part 1. Ophthalmology. 2004;111(5):997–1008.PubMedGoogle Scholar
  211. 211.
    Ferry JA, et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol. 2007;31(2):170–84.PubMedGoogle Scholar
  212. 212.
    Sjo LD, et al. Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Invest Ophthalmol Vis Sci. 2008;49(8):3283–8.PubMedGoogle Scholar
  213. 213.
    Henderson JW, Banks PM, Yeatts RP. T-cell lymphoma of the orbit. Mayo Clin Proc. 1989;64(8):940–4.PubMedGoogle Scholar
  214. 214.
    Chan CC, et al. Detection of Helicobacter pylori and Chlamydia pneumoniae genes in primary orbital lymphoma. Trans Am Ophthalmol Soc. 2006;104:62–70.PubMedCentralPubMedGoogle Scholar
  215. 215.
    Jakobiec FA. Ocular adnexal lymphoid tumors: progress in need of clarification. Am J Ophthalmol. 2008;145(6):941–50.PubMedGoogle Scholar
  216. 216.
    Sjo LD, et al. Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study. Br J Ophthalmol. 2006;90(8):1004–9.PubMedCentralPubMedGoogle Scholar
  217. 217.
    Coupland SE, Damato B. Lymphomas involving the eye and the ocular adnexa. Curr Opin Ophthalmol. 2006;17(6):523–31.PubMedGoogle Scholar
  218. 218.
    Sjo LD, et al. Extranodal marginal zone lymphoma in the ocular region: clinical, immunophenotypical, and cytogenetical characteristics. Invest Ophthalmol Vis Sci. 2009;50(2):516–22.PubMedGoogle Scholar
  219. 219.
    Coupland SE, Hummel M, Stein H. Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv Ophthalmol. 2002;47(5):470–90.PubMedGoogle Scholar
  220. 220.
    Coupland SE, et al. A TNM-based clinical staging system of ocular adnexal lymphomas. Arch Pathol Lab Med. 2009;133(8):1262–7.PubMedGoogle Scholar
  221. 221.
    Uno T, et al. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Cancer. 2003;98(4):865–71.PubMedGoogle Scholar
  222. 222.
    Faridpooya K, et al. Precursor B lymphoblastic lymphoma of the orbit in a child: an unusual presentation of a non-Hodgkin lymphoma. Orbit. 2006;25(2):153–7.PubMedGoogle Scholar
  223. 223.
    Sahjpaul R, Elisevich K, Allen L. Hodgkin’s disease of the orbit with intracranial extension. Ophthalmic Surg Lasers. 1996;27(3):239–42.PubMedGoogle Scholar
  224. 224.
    Rodman HI, Font RL. Orbital involvement in multiple myeloma. Review of the literature and report of three cases. Arch Ophthalmol. 1972;87(1):30–5.PubMedGoogle Scholar
  225. 225.
    Howling SJ, et al. Case report: the CT features of orbital multiple myeloma. Clin Radiol. 1998;53(4):304–5.PubMedGoogle Scholar
  226. 226.
    Ranchod TM, et al. Waldenstrom macroglobulinemia of the orbit. Ophthal Plast Reconstr Surg. 2008;24(1):76–7.PubMedGoogle Scholar
  227. 227.
    Ohta K, et al. Primary granulocytic sarcoma in the sphenoidal bone and orbit. Childs Nerv Syst. 2003;19(9):674–9.PubMedGoogle Scholar
  228. 228.
    Russo V, et al. Orbital and ocular manifestations of acute childhood leukemia: clinical and statistical analysis of 180 patients. Eur J Ophthalmol. 2008;18(4):619–23.PubMedGoogle Scholar
  229. 229.
    Mangla D, Dewan M, Meyer DR. Adult orbital myeloid sarcoma (granulocytic sarcoma): two cases and review of the literature. Orbit. 2012;31(6):438–40.PubMedGoogle Scholar
  230. 230.
    Herwig MC, et al. Langerhans cell histiocytosis of the orbit: five clinicopathologic cases and review of the literature. Surv Ophthalmol. 2013;58(4):330–40.PubMedCentralPubMedGoogle Scholar
  231. 231.
    Haroche J, Arnaud L, Amoura Z. Erdheim-Chester disease. Curr Opin Rheumatol. 2012;24(1):53–9.PubMedGoogle Scholar
  232. 232.
    Haroche J, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood. 2013;121(9):1495–500.PubMedGoogle Scholar
  233. 233.
    Vemuganti GK, Naik MN, Honavar SG. Rosai dorfman disease of the orbit. J Hematol Oncol. 2008;1:7.PubMedCentralPubMedGoogle Scholar
  234. 234.
    Alyahya GA, Prause JU, Heegaard S. Castleman’s disease in the orbit. A 20-year follow-up. Acta Ophthalmol Scand. 2002;80(5):540–2.PubMedGoogle Scholar
  235. 235.
    Venizelos I, et al. Orbital involvement in Castleman disease. Surv Ophthalmol. 2010;55(3):247–55.PubMedGoogle Scholar
  236. 236.
    Ratnatunga N, et al. Primary biphasic synovial sarcoma of the orbit. J Clin Pathol. 1992;45(3):265–7.PubMedCentralPubMedGoogle Scholar
  237. 237.
    Votruba M, et al. Primary monophasic synovial sarcoma of the conjunctiva. Br J Ophthalmol. 2002;86(12):1453–4.PubMedCentralPubMedGoogle Scholar
  238. 238.
    Liu K, et al. Primary synovial sarcoma in the orbit. J AAPOS. 2012;16(6):582–4.PubMedGoogle Scholar
  239. 239.
    Wladis EJ, Farber MG, Nepo AG. Metastatic synovial sarcoma to the orbit. Ophthal Plast Reconstr Surg. 2012;28(6):e131–2.PubMedGoogle Scholar
  240. 240.
    Gunduz K, et al. Malignant rhabdoid tumor of the orbit. Arch Ophthalmol. 1998;116(2):243–6.PubMedGoogle Scholar
  241. 241.
    Kook KH, et al. A case of congenital orbital malignant rhabdoid tumor: systemic metastasis following exenteration. Ophthalmologica. 2009;223(4):274–8.PubMedCentralPubMedGoogle Scholar
  242. 242.
    Gunduz K, et al. Periorbital cellular blue nevus leading to orbitopalpebral and intracranial melanoma. Ophthalmology. 1998;105(11):2046–50.PubMedGoogle Scholar
  243. 243.
    Nakanishi K, et al. Recurrent melanotic neuroectodermal tumor in the orbit successfully treated with resection followed by pediculated periosteal flaps. Pediatr Blood Cancer. 2008;51(3):430–2.PubMedGoogle Scholar
  244. 244.
    Kapadia SB, et al. Melanotic neuroectodermal tumor of infancy. Clinicopathological, immunohistochemical, and flow cytometric study. Am J Surg Pathol. 1993;17(6):566–73.PubMedGoogle Scholar
  245. 245.
    Makhdoomi R, et al. Orbital paraganglioma – a case report and review of the literature. Clin Neuropathol. 2010;29(2):100–4.PubMedGoogle Scholar
  246. 246.
    Mititelu M, Stanton CA, Yeatts RP. Primary neuroendocrine tumor of the orbit progressing to neoplastic meningitis. Ophthal Plast Reconstr Surg. 2008;24(3):231–3.PubMedGoogle Scholar
  247. 247.
    Rose AM, Kabiru J, Rose GE. Alveolar soft-part sarcoma of the orbit. Afr J Paediatr Surg. 2011;8(1):82–4.PubMedGoogle Scholar
  248. 248.
    Joyama S, et al. Chromosome rearrangement at 17q25 and xp11.2 in alveolar soft-part sarcoma: a case report and review of the literature. Cancer. 1999;86(7):1246–50.PubMedGoogle Scholar
  249. 249.
    Daigeler A, et al. Alveolar soft part sarcoma: clinicopathological findings in a series of 11 cases. World J Surg Oncol. 2008;6:71.PubMedCentralPubMedGoogle Scholar
  250. 250.
    Gunalp I, Gunduz K. Secondary orbital tumors. Ophthal Plast Reconstr Surg. 1997;13(1):31–5.PubMedGoogle Scholar
  251. 251.
    Krishna M. Diagnosis of metastatic neoplasms: an immunohistochemical approach. Arch Pathol Lab Med. 2010;134(2):207–15.PubMedGoogle Scholar
  252. 252.
    von Holstein SL, et al. Lacrimal gland lesions in Denmark between 1974 and 2007. Acta Ophthalmol. 2013;91(4):349–54.Google Scholar
  253. 253.
    de la Cuadra-Blanco C, Peces-Pena MD, Merida-Velasco JR. Morphogenesis of the human lacrimal gland. J Anat. 2003;203(5):531–6.PubMedCentralPubMedGoogle Scholar
  254. 254.
    Makarenkova HP, et al. FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development. Development. 2000;127(12):2563–72.PubMedGoogle Scholar
  255. 255.
    Kural G, Serifoglu A, Erture S. A case of aberrant lacrimal gland and fistula. Br J Ophthalmol. 1989;73(5):376–7.PubMedCentralPubMedGoogle Scholar
  256. 256.
    O’Connor MA, Archer DB, Hart PM. Congenital fistulae of the lacrimal gland. Br J Ophthalmol. 1985;69(9):711–3.PubMedCentralPubMedGoogle Scholar
  257. 257.
    Wieczorek R, et al. The immunoarchitecture of the normal human lacrimal gland. Relevancy for understanding pathologic conditions. Ophthalmology. 1988;95(1):100–9.PubMedGoogle Scholar
  258. 258.
    Knop E, Knop N. Lacrimal drainage-associated lymphoid tissue (LDALT): a part of the human mucosal immune system. Invest Ophthalmol Vis Sci. 2001;42(3):566–74.PubMedGoogle Scholar
  259. 259.
    Rai P, Shah SA, Kirshan H. Acute Dacryadenitis-analysis of 23 cases. Med Channel. 2009;15:71–6.Google Scholar
  260. 260.
    Srivastava V. Acute suppurative dacryoadenitis. Med J Armed Forces India. 2000;56:151–2.Google Scholar
  261. 261.
    Shields CL, et al. Clinicopathologic review of 142 cases of lacrimal gland lesions. Ophthalmology. 1989;96(4):431–5.PubMedGoogle Scholar
  262. 262.
    Hurwitz JJ. A practical approach to the management of lacrimal gland lesions. Ophthalmic Surg. 1982;13(10):829–36.PubMedGoogle Scholar
  263. 263.
    Al-Hashimi I, et al. Frequency and predictive value of the clinical manifestations in Sjogren’s syndrome. J Oral Pathol Med. 2001;30(1):1–6.PubMedGoogle Scholar
  264. 264.
    Jakobiec FA, Stacy RC, Hatton MP. Clinical characterization and immunopathologic features of sclerosing dacryoadenitis and riedel thyroiditis. Arch Ophthalmol. 2010;128(12):1626–8.PubMedGoogle Scholar
  265. 265.
    Burkhalter E. Unique presentation of systemic lupus erythematosus. Arthritis Rheum. 1973;16(3):428.PubMedGoogle Scholar
  266. 266.
    Pulido JS, et al. Ocular manifestations of patients with circulating antineutrophil cytoplasmic antibodies. Arch Ophthalmol. 1990;108(6):845–50.PubMedGoogle Scholar
  267. 267.
    Nahata MC, Sethi PK. Traumatic prolapse of the lacrimal gland. Indian J Ophthalmol. 1973;21(1):43–4.PubMedGoogle Scholar
  268. 268.
    Halborg J, et al. Stones in the lacrimal gland: a rare condition. Acta Ophthalmol. 2009;87(6):672–5.PubMedGoogle Scholar
  269. 269.
    Prabhakaran VC, et al. Amyloidosis of lacrimal gland. Indian J Ophthalmol. 2009;57(6):461–3.PubMedCentralPubMedGoogle Scholar
  270. 270.
    Damato BE, et al. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol. 1984;68(9):674–80.PubMedCentralPubMedGoogle Scholar
  271. 271.
    Shields JA, et al. Classification and incidence of space-occupying lesions of the orbit. A survey of 645 biopsies. Arch Ophthalmol. 1984;102(11):1606–11.PubMedGoogle Scholar
  272. 272.
    Kennedy RE. An evaluation of 820 orbital cases. Trans Am Ophthalmol Soc. 1984;82:134–57.PubMedCentralPubMedGoogle Scholar
  273. 273.
    Ni C, Kuo PK, Dryja TP. Histopathological classification of 272 primary epithelial tumors of the lacrimal gland. Chin Med J (Engl). 1992;105(6):481–5.Google Scholar
  274. 274.
    Shields JA, et al. Review: primary epithelial malignancies of the lacrimal gland: the 2003 Ramon L. Font lecture. Ophthal Plast Reconstr Surg. 2004;20(1):10–21.PubMedGoogle Scholar
  275. 275.
    Barnes L, et al. Pathology and genetics of head and neck tumours. 3rd ed. World Health Organization Classification of Tumours, vol 9. Lyon: IARC Press; 2005.Google Scholar
  276. 276.
    Weis E, et al. Epithelial lacrimal gland tumors: pathologic classification and current understanding. Arch Ophthalmol. 2009;127(8):1016–28.PubMedGoogle Scholar
  277. 277.
    von Holstein SL, et al. Granular cell tumour of the lacrimal gland. Acta Ophthalmol. 2009;87(8):926–7.Google Scholar
  278. 278.
    Snaathorst J, et al. Primary epithelial tumors of the lacrimal gland; a retrospective analysis of 22 patients. Int J Oral Maxillofac Surg. 2009;38(7):751–7.PubMedGoogle Scholar
  279. 279.
    Prabhakaran VC, et al. Lesions mimicking lacrimal gland pleomorphic adenoma. Br J Ophthalmol. 2010;94(11):1509–12.PubMedGoogle Scholar
  280. 280.
    Gupta A, Khandelwal A. Lacrimal gland pleomorphic adenoma: an inconceivable diagnosis in a child. BMJ Case Rep. 2013;2013:bcr009138.Google Scholar
  281. 281.
    Vagefi MR, et al. Atypical presentations of pleomorphic adenoma of the lacrimal gland. Ophthal Plast Reconstr Surg. 2007;23(4):272–4.PubMedGoogle Scholar
  282. 282.
    Rose GE, Wright JE. Pleomorphic adenoma of the lacrimal gland. Br J Ophthalmol. 1992;76(7):395–400.PubMedCentralPubMedGoogle Scholar
  283. 283.
    Vangveeravong S, et al. Tumors arising in the palpebral lobe of the lacrimal gland. Ophthalmology. 1996;103(10):1606–12.PubMedGoogle Scholar
  284. 284.
    Ramlee N, Ramli N, Tajudin LS. Pleomorphic adenoma in the palpebral lobe of the lacrimal gland misdiagnosed as chalazion. Orbit. 2007;26(2):137–9.PubMedGoogle Scholar
  285. 285.
    Sen S, et al. Pleomorphic adenomas of the lacrimal gland: a clinicopathological analysis. Clin Exp Ophthalmol. 2004;32(5):523–5.Google Scholar
  286. 286.
    McNab AA, Satchi K. Recurrent lacrimal gland pleomorphic adenoma: clinical and computed tomography features. Ophthalmology. 2011;118(10):2088–92.PubMedGoogle Scholar
  287. 287.
    Tong JT, et al. Benign mixed tumor arising from an accessory lacrimal gland of Wolfring. Ophthal Plast Reconstr Surg. 1995;11(2):136–8.PubMedGoogle Scholar
  288. 288.
    Saini JS, Mukherjee AK, Naik P. Pleomorphic adenoma of Krause’s gland in lower lid. Indian J Ophthalmol. 1985;33(3):181–2.PubMedGoogle Scholar
  289. 289.
    Venkataramayya K. Pleomorphic adenoma of Krause’s gland. Indian J Ophthalmol. 1976;23(4):38–9.PubMedGoogle Scholar
  290. 290.
    Grossniklaus HE, Abbuhl MF, McLean IW. Immunohistologic properties of benign and malignant mixed tumor of the lacrimal gland. Am J Ophthalmol. 1990;110(5):540–9.PubMedGoogle Scholar
  291. 291.
    Zhao M, et al. Immunohistochemical demonstration of bone morphogenetic protein-2 and type II collagen in pleomorphic adenoma of salivary glands. J Oral Pathol Med. 1998;27(7):293–6.PubMedGoogle Scholar
  292. 292.
    Dardick I. Mounting evidence against current histogenetic concepts for salivary gland tumorigenesis. Eur J Morphol. 1998;36(Suppl):257–61.PubMedGoogle Scholar
  293. 293.
    Margaritescu C, et al. Tumoral stroma of salivary pleomorphic adenoma – histopathological, histochemical and immunohistochemical study. Rom J Morphol Embryol. 2005;46(3):211–23.PubMedGoogle Scholar
  294. 294.
    Bullerdiek J, et al. Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet. 1993;65(1):27–31.PubMedGoogle Scholar
  295. 295.
    Alyahya GA, et al. Pleomorphic adenoma arising in an accessory lacrimal gland of Wolfring. Ophthalmology. 2006;113(5):879–82.PubMedGoogle Scholar
  296. 296.
    Maran AG, Mackenzie IJ, Stanley RE. Recurrent pleomorphic adenomas of the parotid gland. Arch Otolaryngol. 1984;110(3):167–71.PubMedGoogle Scholar
  297. 297.
    Font FR, Gamel JW. Epithelial tumors of the lacrimal gland: analysis of 265 cases. In: Jakobiec FA, editor. Ocular and adnexal tumors. Birmingham: Aesculapius; 1978. p. 787–805.Google Scholar
  298. 298.
    Chandrasekhar J, Farr DR, Whear NM. Pleomorphic adenoma of the lacrimal gland: case report. Br J Oral Maxillofac Surg. 2001;39(5):390–3.PubMedGoogle Scholar
  299. 299.
    Bonavolonta G, et al. Warthin tumor of the lacrimal gland. Am J Ophthalmol. 1997;124(6):857–8.PubMedGoogle Scholar
  300. 300.
    Thompson AS, Bryant Jr HC. Histogenesis of papillary cystadenoma lymphomatosum (Warthin’s tumor) of the parotid salivary gland. Am J Pathol. 1950;26(5):807–49.PubMedCentralPubMedGoogle Scholar
  301. 301.
    Kleinsasser O, Klein HJ. Basal cell adenoma of the salivary glands. Arch Klin Exp Ohren Nasen Kehlkopfheilkd. 1967;189(3):302–16.PubMedGoogle Scholar
  302. 302.
    Zarbo RJ, et al. Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations. Arch Pathol Lab Med. 2000;124(3):401–5.PubMedGoogle Scholar
  303. 303.
    Silbert JE, Braich P, Misra RP. Basal cell cystadenoma of the lacrimal gland: diagnostic pitfalls of a basaloid pattern in lacrimal tumours. Int Ophthalmol. 2011;31(1):43–6.PubMedGoogle Scholar
  304. 304.
    Khalil M, Arthurs B. Basal cell adenocarcinoma of the lacrimal gland. Ophthalmology. 2000;107(1):164–8.PubMedGoogle Scholar
  305. 305.
    Hartman LJ, Mourits MP, Canninga-van Dijk MR. An unusual tumour of the lacrimal gland. Br J Ophthalmol. 2003;87(3):363.PubMedCentralPubMedGoogle Scholar
  306. 306.
    Economou MA, Seregard S, Sahlin S. Oncocytoma of the lacrimal gland. Acta Ophthalmol Scand. 2007;85(5):576–7.PubMedGoogle Scholar
  307. 307.
    Ostergaard J, Prause JU, Heegaard S. Oncocytic lesions of the ophthalmic region: a clinicopathological study with emphasis on cytokeratin expression. Acta Ophthalmol. 2011;89(3):263–7.PubMedGoogle Scholar
  308. 308.
    Riedel K, Stefani FH, Kampik A. Oncocytoma of the ocular adnexa. Klin Monbl Augenheilkd. 1983;182(6):544–8.PubMedGoogle Scholar
  309. 309.
    Tandler B. Fine structure of oncocytes in human salivary glands. Virchows Arch Pathol Anat Physiol Klin Med. 1966;341(4):317–26.PubMedGoogle Scholar
  310. 310.
    Prasad AR, et al. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med. 1999;123(9):801–6.PubMedGoogle Scholar
  311. 311.
    Calle CA, et al. Oncocytoma of the lacrimal gland: case report and review of the literature. Orbit. 2006;25(3):243–7.PubMedGoogle Scholar
  312. 312.
    Hamperl H. Benign and malignant oncocytoma. Cancer. 1962;15:1019–27.PubMedGoogle Scholar
  313. 313.
    Porcelli AM, et al. The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization. Hum Mol Genet. 2010;19(6):1019–32.PubMedGoogle Scholar
  314. 314.
    Font RL, Garner A. Myoepithelioma of the lacrimal gland: report of a case with spindle cell morphology. Br J Ophthalmol. 1992;76(10):634–6.PubMedCentralPubMedGoogle Scholar
  315. 315.
    Grossniklaus HE, et al. Myoepithelioma of the lacrimal gland. Arch Ophthalmol. 1997;115(12):1588–90.PubMedGoogle Scholar
  316. 316.
    Bolzoni A, et al. Benign myoepithelioma of the lacrimal gland: report of a case. Eur Arch Otorhinolaryngol. 2005;262(3):186–8.PubMedGoogle Scholar
  317. 317.
    Sassano P, et al. Interleukine-6 (IL-6) may be a link between myasthenia gravis and myoepithelioma of the parotid gland. Med Hypotheses. 2007;68(2):314–7.PubMedGoogle Scholar
  318. 318.
    Jaeger RG, et al. Expression of smooth-muscle actin in cultured cells from human plasmacytoid myoepithelioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84(6):663–7.PubMedGoogle Scholar
  319. 319.
    el-Naggar AK, et al. Cytogenetic analysis of a primary salivary gland myoepithelioma. Cancer Genet Cytogenet. 1999;113(1):49–53.PubMedGoogle Scholar
  320. 320.
    Okudela K, et al. Myoepithelioma of the lacrimal gland: report of a case with potentially malignant transformation. Pathol Int. 2000;50(3):238–43.PubMedGoogle Scholar
  321. 321.
    Font RL, Smith SL, Bryan RG. Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases. Arch Ophthalmol. 1998;116(5):613–6.PubMedGoogle Scholar
  322. 322.
    Ferry AP, Font RL. Carcinoma metastatic to the orbit. Mod Probl Ophthalmol. 1975;14:377–81.PubMedGoogle Scholar
  323. 323.
    Stell PM. Adenoid cystic carcinoma. Clin Otolaryngol Allied Sci. 1986;11(4):267–91.PubMedGoogle Scholar
  324. 324.
    Paulino AF, Huvos AG. Epithelial tumors of the lacrimal glands: a clinicopathologic study. Ann Diagn Pathol. 1999;3(4):199–204.PubMedGoogle Scholar
  325. 325.
    Henderson JW. Intrinsic neoplasms of the lacrimal gland. In: Henderson JW, editor. Orbital tumors. Philadelphia: W.B. Saunders; 1973. p. 409–43.Google Scholar
  326. 326.
    Font RL, Croxatto JO, Rao NA. Tumors of the lacrimal gland. In: Tumors of the eye and ocular adnexa. Washington, DC: American Registry of Pathology/Armed Forces Institute of Pathology; 2006. p. 223–346.Google Scholar
  327. 327.
    Zhou Q, et al. Increased numbers of P63-positive/CD117-positive cells in advanced adenoid cystic carcinoma give a poorer prognosis. Diagn Pathol. 2012;7:119.PubMedCentralPubMedGoogle Scholar
  328. 328.
    Seethala RR, et al. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol. 2007;31(11):1683–94.PubMedGoogle Scholar
  329. 329.
    Szanto PA, et al. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984;54(6):1062–9.PubMedGoogle Scholar
  330. 330.
    Chau Y, et al. Dedifferentiation of adenoid cystic carcinoma: report of a case implicating p53 gene mutation. Hum Pathol. 2001;32(12):1403–7.PubMedGoogle Scholar
  331. 331.
    Esmaeli B, et al. Surgical management of locally advanced adenoid cystic carcinoma of the lacrimal gland. Ophthal Plast Reconstr Surg. 2006;22(5):366–70.PubMedGoogle Scholar
  332. 332.
    Woo VL, Bhuiya T, Kelsch R. Assessment of CD43 expression in adenoid cystic carcinomas, polymorphous low-grade adenocarcinomas, and monomorphic adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(4):495–500.PubMedGoogle Scholar
  333. 333.
    von Holstein SL, et al. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics. Ophthalmology. 2013;120:2130–8.Google Scholar
  334. 334.
    Mitani Y, et al. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010;16(19):4722–31.PubMedGoogle Scholar
  335. 335.
    Seethala RR. Histologic grading and prognostic biomarkers in salivary gland carcinomas. Adv Anat Pathol. 2011;18(1):29–45.PubMedGoogle Scholar
  336. 336.
    Le Tourneau C, et al. Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland. Br J Ophthalmol. 2011;95(11):1483–9.PubMedGoogle Scholar
  337. 337.
    Jaso J, Malhotra R. Adenoid cystic carcinoma. Arch Pathol Lab Med. 2011;135(4):511–5.PubMedGoogle Scholar
  338. 338.
    Zhang J, Peng B. In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland adenoid cystic carcinoma. BMC Cancer. 2007;7:95.PubMedCentralPubMedGoogle Scholar
  339. 339.
    Preisegger KH, et al. Prognostic impact of molecular analyses in adenoid cystic carcinomas of the salivary gland. Onkologie. 2001;24(3):273–7.PubMedGoogle Scholar
  340. 340.
    Gamel JW, Font RL. Adenoid cystic carcinoma of the lacrimal gland: the clinical significance of a basaloid histologic pattern. Hum Pathol. 1982;13(3):219–25.PubMedGoogle Scholar
  341. 341.
    Rao PH, et al. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res. 2008;14(16):5181–7.PubMedGoogle Scholar
  342. 342.
    Luna MA, et al. Flow cytometric DNA content of adenoid cystic carcinoma of submandibular gland. Correlation of histologic features and prognosis. Arch Otolaryngol Head Neck Surg. 1990;116(11):1291–6.PubMedGoogle Scholar
  343. 343.
    Lee DA, et al. A clinicopathologic study of primary adenoid cystic carcinoma of the lacrimal gland. Ophthalmology. 1985;92(1):128–34.PubMedGoogle Scholar
  344. 344.
    Esmaeli B, et al. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthal Plast Reconstr Surg. 2004;20(1):22–6.PubMedGoogle Scholar
  345. 345.
    Lin YC, et al. Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas. Int J Oral Maxillofac Surg. 2012;41(3):354–60.PubMedGoogle Scholar
  346. 346.
    Bernardini FP, Devoto MH, Croxatto JO. Epithelial tumors of the lacrimal gland: an update. Curr Opin Ophthalmol. 2008;19(5):409–13.PubMedGoogle Scholar
  347. 347.
    Hu YH, et al. Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma. Arch Pathol Lab Med. 2011;135(7):882–9.PubMedGoogle Scholar
  348. 348.
    Currie ZI, Rose GE. Long-term risk of recurrence after intact excision of pleomorphic adenomas of the lacrimal gland. Arch Ophthalmol. 2007;125(12):1643–6.PubMedGoogle Scholar
  349. 349.
    Ahn JY, et al. Pleomorphic adenocarcinoma of the lacrimal gland with multiple intracranial and spinal metastases. World J Surg Oncol. 2007;5:29.PubMedCentralPubMedGoogle Scholar
  350. 350.
    Yamasaki T, et al. Multiple intracranial metastases following malignant evolution in recurrent pleomorphic adenoma of the lacrimal gland – case report. Neurol Med Chir (Tokyo). 1990;30(13):1038–42.Google Scholar
  351. 351.
    Chang CJ, et al. Carcinoma ex pleomorphic adenoma of the lacrimal gland: a case report. Ann Ophthalmol (Skokie). 2006;38(2):141–4.Google Scholar
  352. 352.
    Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck. 2001;23(9):705–12.PubMedGoogle Scholar
  353. 353.
    Galatoire O, et al. Adenocarcinoma in a pleomorphic adenoma of the lacrimal gland: a case study. J Fr Ophtalmol. 2005;28(8):896–901.PubMedGoogle Scholar
  354. 354.
    Takahira M, et al. Cystic carcinoma ex pleomorphic adenoma of the lacrimal gland. Ophthal Plast Reconstr Surg. 2007;23(5):407–9.PubMedGoogle Scholar
  355. 355.
    Perzin KH, et al. Lacrimal gland malignant mixed tumors (carcinomas arising in benign mixed tumors): a clinico-pathologic study. Cancer. 1980;45(10):2593–606.PubMedGoogle Scholar
  356. 356.
    Ishida M, et al. Case of ductal adenocarcinoma ex pleomorphic adenoma of the lacrimal gland. Rinsho Byori. 2009;57(8):746–51.PubMedGoogle Scholar
  357. 357.
    Harada H. Histomorphological investigation regarding to malignant transformation of pleomorphic adenoma (so-called malignant mixed tumor) of the salivary gland origin: special reference to carcinosarcoma. Kurume Med J. 2000;47(4):307–23.PubMedGoogle Scholar
  358. 358.
    Takahira M, et al. Carcinosarcoma of the lacrimal gland arising from a pleomorphic adenoma. Am J Ophthalmol. 2005;140(2):337–40.PubMedGoogle Scholar
  359. 359.
    Mensink HW, Mooy C, Paridaens D. In situ adenocarcinoma ex pleomorphic adenoma of the lacrimal gland. Clin Exp Ophthalmol. 2005;33(6):669–71.Google Scholar
  360. 360.
    Tortoledo ME, Luna MA, Batsakis JG. Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch Otolaryngol. 1984;110(3):172–6.PubMedGoogle Scholar
  361. 361.
    Cheuk W, Chan JK. Advances in salivary gland pathology. Histopathology. 2007;51(1):1–20.PubMedGoogle Scholar
  362. 362.
    Ohtake S, et al. Precancerous foci in pleomorphic adenoma of the salivary gland: recognition of focal carcinoma and atypical tumor cells by P53 immunohistochemistry. J Oral Pathol Med. 2002;31(10):590–7.PubMedGoogle Scholar
  363. 363.
    Rosa JC, et al. Immunohistochemical study of c-erbB-2 expression in carcinoma ex-pleomorphic adenoma. Histopathology. 1996;28(3):247–52.PubMedGoogle Scholar
  364. 364.
    El-Naggar AK, et al. Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model? Gene Chromosome Cancer. 2000;27(2):162–8.Google Scholar
  365. 365.
    Baek SO, et al. Primary adenocarcinoma of the lacrimal gland. Arch Plast Surg. 2012;39(5):578–80.PubMedCentralPubMedGoogle Scholar
  366. 366.
    Clauser L, et al. Adenocarcinoma of the lacrimal gland: report of a case. J Oral Maxillofac Surg. 2002;60(3):318–21.PubMedGoogle Scholar
  367. 367.
    Sofinski SJ, et al. Mucoepidermoid carcinoma of the lacrimal gland. Case report and review of the literature. Ophthal Plast Reconstr Surg. 1986;2(3):147–51.PubMedGoogle Scholar
  368. 368.
    Eviatar JA, Hornblass A. Mucoepidermoid carcinoma of the lacrimal gland: 25 cases and a review and update of the literature. Ophthal Plast Reconstr Surg. 1993;9(3):170–81.PubMedGoogle Scholar
  369. 369.
    Isayeva T, et al. Salivary mucoepidermoid carcinoma: demonstration of transcriptionally active human papillomavirus 16/18. Head Neck Pathol. 2013;7(2):135–48.PubMedCentralPubMedGoogle Scholar
  370. 370.
    Dithmar S, et al. Mucoepidermoid carcinoma of an accessory lacrimal gland with orbital invasion. Ophthal Plast Reconstr Surg. 2000;16(2):162–6.PubMedGoogle Scholar
  371. 371.
    Pulitzer DR, Eckert ER. Mucoepidermoid carcinoma of the lacrimal gland. An oxyphilic variant. Arch Ophthalmol. 1987;105(10):1406–9.PubMedGoogle Scholar
  372. 372.
    Levin LA, et al. Mucoepidermoid carcinoma of the lacrimal gland. Report of a case with oncocytic features arising in a patient with chronic dacryops. Ophthalmology. 1991;98(10):1551–5.PubMedGoogle Scholar
  373. 373.
    Brandwein MS, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25(7):835–45.PubMedGoogle Scholar
  374. 374.
    Von Holstein SL, et al. CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland. Oncol Rep. 2012;27(5):1413–6.Google Scholar
  375. 375.
    Behboudi A, et al. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Gene Chromosome Cancer. 2006;45(5):470–81.Google Scholar
  376. 376.
    Yoo J, Robinson RA. H-ras gene mutations in salivary gland mucoepidermoid carcinomas. Cancer. 2000;88(3):518–23.PubMedGoogle Scholar
  377. 377.
    Handra-Luca A, et al. MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol. 2005;29(7):881–9.PubMedGoogle Scholar
  378. 378.
    Katz SE, et al. Primary ductal adenocarcinoma of the lacrimal gland. Ophthalmology. 1996;103(1):157–62.PubMedGoogle Scholar
  379. 379.
    Kubota T, Moritani S, Ichihara S. Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: five new cases and review of literature. Graefes Arch Clin Exp Ophthalmol. 2013;251(8):2071–6.PubMedGoogle Scholar
  380. 380.
    Di Palma S, et al. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes*. Histopathology. 2012;61(4):629–43.PubMedGoogle Scholar
  381. 381.
    Wright JE, Rose GE, Garner A. Primary malignant neoplasms of the lacrimal gland. Br J Ophthalmol. 1992;76(7):401–7.PubMedCentralPubMedGoogle Scholar
  382. 382.
    Fenton S, et al. Primary squamous cell carcinoma of the lacrimal gland. Eye (Lond). 2003;17(3):424–5.Google Scholar
  383. 383.
    Su GW, Patipa M, Font RL. Primary squamous cell carcinoma arising from an epithelium-lined cyst of the lacrimal gland. Ophthal Plast Reconstr Surg. 2005;21(5):383–5.PubMedGoogle Scholar
  384. 384.
    Hotta K, et al. Primary squamous cell carcinoma of the lacrimal gland. Clin Exp Ophthalmol. 2005;33(5):534–6.Google Scholar
  385. 385.
    Briscoe D, et al. Primary sebaceous carcinoma of the lacrimal gland. Br J Ophthalmol. 2001;85(5):625–6.PubMedCentralPubMedGoogle Scholar
  386. 386.
    Mooy CM. Intraepithelial sebaceous neoplasia invading the lacrimal gland. Br J Ophthalmol. 1997;81(7):612–3.PubMedGoogle Scholar
  387. 387.
    Konrad EA, Thiel HJ. Adenocarcinoma of the lacrimal gland with sebaceous differentiation. A clinical study using light and electron microscopy. Graefes Arch Clin Exp Ophthalmol. 1983;221(2):81–5.PubMedGoogle Scholar
  388. 388.
    Chan JK, et al. Specific association of Epstein-Barr virus with lymphoepithelial carcinoma among tumors and tumorlike lesions of the salivary gland. Arch Pathol Lab Med. 1994;118(10):994–7.PubMedGoogle Scholar
  389. 389.
    Singhi AD, et al. Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma. Am J Surg Pathol. 2010;34(6):800–5.PubMedGoogle Scholar
  390. 390.
    Rao NA, et al. Lymphoepithelial carcinoma of the lacrimal gland. Arch Ophthalmol. 2002;120(12):1745–8.PubMedGoogle Scholar
  391. 391.
    Liu YT, et al. Lymphoepithelial carcinoma of the lacrimal sac. Eye (Lond). 2009;23(7):1612–5.Google Scholar
  392. 392.
    Bloching M, Hinze R, Berghaus A. Lymphepithelioma-like carcinoma of the lacrimal gland. Eur Arch Otorhinolaryngol. 2000;257(7):399–401.PubMedGoogle Scholar
  393. 393.
    Evans HL, Batsakis JG. Polymorphous low-grade adenocarcinoma of minor salivary glands. A study of 14 cases of a distinctive neoplasm. Cancer. 1984;53(4):935–42.PubMedGoogle Scholar
  394. 394.
    Selva D, et al. Polymorphous low-grade adenocarcinoma of the lacrimal gland. Arch Ophthalmol. 2004;122(6):915–7.PubMedGoogle Scholar
  395. 395.
    Castle JT, et al. Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer. 1999;86(2):207–19.PubMedGoogle Scholar
  396. 396.
    Kemp BL, et al. Terminal duct adenocarcinomas of the parotid gland. J Laryngol Otol. 1995;109(5):466–8.PubMedGoogle Scholar
  397. 397.
    Evans HL, Luna MA. Polymorphous low-grade adenocarcinoma: a study of 40 cases with long-term follow up and an evaluation of the importance of papillary areas. Am J Surg Pathol. 2000;24(10):1319–28.PubMedGoogle Scholar
  398. 398.
    Wiwatwongwana D, et al. Unusual carcinomas of the lacrimal gland: epithelial-myoepithelial carcinoma and myoepithelial carcinoma. Arch Ophthalmol. 2009;127(8):1054–6.PubMedGoogle Scholar
  399. 399.
    Ostrowski ML, et al. Clear cell epithelial-myoepithelial carcinoma arising in pleomorphic adenoma of the lacrimal gland. Ophthalmology. 1994;101(5):925–30.PubMedGoogle Scholar
  400. 400.
    Singh G, et al. Epithelial-myoepithelial carcinoma of the lacrimal gland: a rare case. Ann Diagn Pathol. 2012;16(4):292–7.PubMedGoogle Scholar
  401. 401.
    Chetty R. Intercalated duct hyperplasia: possible relationship to epithelial-myoepithelial carcinoma and hybrid tumours of salivary gland. Histopathology. 2000;37(3):260–3.PubMedGoogle Scholar
  402. 402.
    Watt FM, Hogan BL. Out of Eden: stem cells and their niches. Science. 2000;287(5457):1427–30.PubMedGoogle Scholar
  403. 403.
    Daa T, et al. Epithelial-myoepithelial carcinoma harboring p53 mutation. APMIS. 2001;109(4):316–20.PubMedGoogle Scholar
  404. 404.
    Furuse C, et al. Beta-catenin and E-cadherin expression in salivary gland tumors. Int J Surg Pathol. 2006;14(3):212–7.PubMedGoogle Scholar
  405. 405.
    Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol. 2007;31(1):44–57.PubMedGoogle Scholar
  406. 406.
    Tralongo V, Daniele E. Epithelial-myoepithelial carcinoma of the salivary glands: a review of literature. Anticancer Res. 1998;18(1B):603–8.PubMedGoogle Scholar
  407. 407.
    Devoto MH, Croxatto JO. Primary cystadenocarcinoma of the lacrimal gland. Ophthalmology. 2003;110(10):2006–10.PubMedGoogle Scholar
  408. 408.
    Peng X, et al. Papillary cystadenocarcinoma of the lacrimal gland. Ann Ophthalmol (Skokie). 2010;42 Spec No:15–9.Google Scholar
  409. 409.
    Foss RD, Ellis GL, Auclair PL. Salivary gland cystadenocarcinomas. A clinicopathologic study of 57 cases. Am J Surg Pathol. 1996;20(12):1440–7.PubMedGoogle Scholar
  410. 410.
    De Rosa G, et al. Acinic cell carcinoma arising in a lacrimal gland. First case report. Cancer. 1986;57(10):1988–91.PubMedGoogle Scholar
  411. 411.
    Jang J, et al. Acinic cell carcinoma of the lacrimal gland with intracranial extension: a case report. Ophthal Plast Reconstr Surg. 2001;17(6):454–7.PubMedGoogle Scholar
  412. 412.
    Nichols AC, et al. A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastases. Case Rep Oncol Med. 2013;2013:270362.PubMedCentralPubMedGoogle Scholar
  413. 413.
    Lewis JE, Olsen KD, Weiland LH. Acinic cell carcinoma. Clinicopathologic review. Cancer. 1991;67(1):172–9.PubMedGoogle Scholar
  414. 414.
    Hoffman HT, et al. National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma. Head Neck. 1999;21(4):297–309.PubMedGoogle Scholar
  415. 415.
    Piana S, et al. Dedifferentiated acinic cell carcinoma of the parotid gland with myoepithelial features. Arch Pathol Lab Med. 2002;126(9):1104–5.PubMedGoogle Scholar
  416. 416.
    Muduly DK, et al. Basal cell adenocarcinoma of lacrimal gland. Orbit. 2011;30(6):300–2.PubMedGoogle Scholar
  417. 417.
    Lee GA, Cominos D, Sullivan TJ. Clinicopathological report: mucinous carcinoma of the eyelid. Aust N Z J Ophthalmol. 1999;27(1):71–3.PubMedGoogle Scholar
  418. 418.
    Uchida K, et al. Screening for DNA copy number aberrations in mucinous adenocarcinoma arising from the minor salivary gland: two case reports. Cancer Genet Cytogenet. 2010;203(2):324–7.PubMedGoogle Scholar
  419. 419.
    Kalantzis G, et al. Oncocytic adenocarcinoma of the lacrimal gland: an unusual presentation. Eye (Lond). 2013;27(1):104–5.Google Scholar
  420. 420.
    Dorello U. Carcinoma oncocitario della ghiandola lacrimale. Riv Otoneurooftalmol. 1961;36:452–61.Google Scholar
  421. 421.
    Bernardini FP, Croxatto JO, Bandelloni R. Primary undifferentiated large cell carcinoma of the lacrimal gland. Ophthalmology. 2011;118(6):1189–92.PubMedGoogle Scholar
  422. 422.
    Kivela T, Tarkkanen A. The Merkel cell and associated neoplasms in the eyelids and periocular region. Surv Ophthalmol. 1990;35(3):171–87.PubMedGoogle Scholar
  423. 423.
    Gess AJ, Silkiss RZ. A merkel cell carcinoma of the lacrimal gland. Ophthal Plast Reconstr Surg. 2012;28(1):e11–3.PubMedGoogle Scholar
  424. 424.
    Luaces Rey R, et al. Merkel cell carcinoma of the head and neck: report of seven cases. Med Oral Patol Oral Cir Bucal. 2008;13(6):E390–4.PubMedGoogle Scholar
  425. 425.
    Feng H, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096–100.PubMedCentralPubMedGoogle Scholar
  426. 426.
    Iida K, et al. A case of malignant myoepithelioma in the lacrimal gland. Nihon Ganka Gakkai Zasshi. 2001;105(1):42–6.PubMedGoogle Scholar
  427. 427.
    Cherian I, et al. Adenosquamous carcinoma of the lacrimal gland. BMJ Case Rep. 2010;2010:bcr0720103192.PubMedCentralPubMedGoogle Scholar
  428. 428.
    Rasmussen P, et al. Malignant lymphoma of the lacrimal gland: a nation-based study. Arch Ophthalmol. 2011;129(10):1275–80.PubMedGoogle Scholar
  429. 429.
    Farmer JP, et al. Lymphoproliferative lesions of the lacrimal gland: clinicopathological, immunohistochemical and molecular genetic analysis. Can J Ophthalmol. 2005;40(2):151–60.PubMedGoogle Scholar
  430. 430.
    Sevel D. Development and congenital abnormalities of the nasolacrimal apparatus. J Pediatr Ophthalmol Strabismus. 1981;18(5):13–9.PubMedGoogle Scholar
  431. 431.
    Tucker NA, Tucker SM, Linberg JV. The anatomy of the common canaliculus. Arch Ophthalmol. 1996;114(10):1231–4.PubMedGoogle Scholar
  432. 432.
    Ipek E, et al. Morphological and morphometric evaluation of lacrimal groove. Anat Sci Int. 2007;82(4):207–10.PubMedGoogle Scholar
  433. 433.
    Paul TO. Medical management of congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus. 1985;22(2):68–70.PubMedGoogle Scholar
  434. 434.
    Nelson LR, Calhoun JH, Menduke H. Medical management of congenital nasolacrimal duct obstruction. Ophthalmology. 1985;92(9):1187–90.PubMedGoogle Scholar
  435. 435.
    Petersen RA, Robb RM. The natural course of congenital obstruction of the nasolacrimal duct. J Pediatr Ophthalmol Strabismus. 1978;15(4):246–50.PubMedGoogle Scholar
  436. 436.
    Perry LJ, et al. Giant dacryocystomucopyocele in an adult: a review of lacrimal sac enlargements with clinical and histopathologic differential diagnoses. Surv Ophthalmol. 2012;57(5):474–85.PubMedGoogle Scholar
  437. 437.
    Welham RA, Bergin DJ. Congenital lacrimal fistulas. Arch Ophthalmol. 1985;103(4):545–8.PubMedGoogle Scholar
  438. 438.
    Masi AV. Congenital fistula of the lacrimal sac. Arch Ophthalmol. 1969;81(5):701–4.PubMedGoogle Scholar
  439. 439.
    Oill PA, et al. Specialty conference. Infectious disease emergencies. Part V: patients presenting with localized infections. West J Med. 1977;126(3):196–208.PubMedCentralPubMedGoogle Scholar
  440. 440.
    Marthin JK, et al. Lesions of the lacrimal drainage system: a clinicopathological study of 643 biopsy specimens of the lacrimal drainage system in Denmark 1910–1999. Acta Ophthalmol Scand. 2005;83(1):94–9.PubMedGoogle Scholar
  441. 441.
    Repp DJ, Burkat CN, Lucarelli MJ. Lacrimal excretory system concretions: canalicular and lacrimal sac. Ophthalmology. 2009;116(11):2230–5.PubMedGoogle Scholar
  442. 442.
    Hay-Smith G, Rose GE. Lacrimal gland ductulitis caused by probable Actinomyces infection. Ophthalmology. 2012;119(1):193–6.PubMedGoogle Scholar
  443. 443.
    Murphy CL, Murgatroyd H. Sarcoidosis of the lacrimal sac – an unusual case. Br J Ophthalmol. 2013;97:1351.PubMedGoogle Scholar
  444. 444.
    Litwin AS, et al. Acquired lacrimal sac fistula mimicking basal cell carcinoma. Br J Dermatol. 2013;168(6):1348–50.PubMedGoogle Scholar
  445. 445.
    Marcet MM, et al. Localized orbital amyloidosis involving the lacrimal sac and nasolacrimal duct. Ophthalmology. 2006;113(1):153–6.PubMedGoogle Scholar
  446. 446.
    Kroll J, Busse H. Tumours of the lacrimal passages. Klin Monbl Augenheilkd. 2008;225(1):91–5.PubMedGoogle Scholar
  447. 447.
    Golub JS, et al. Inverted papilloma of the nasolacrimal system invading the orbit. Ophthal Plast Reconstr Surg. 2007;23(2):151–3.PubMedGoogle Scholar
  448. 448.
    Raemdonck TY, et al. Inverted papilloma arising primarily from the lacrimal sac. Orbit. 2009;28(2–3):181–4.PubMedGoogle Scholar
  449. 449.
    Sjo NC, et al. Human papillomavirus: cause of epithelial lacrimal sac neoplasia? Acta Ophthalmol Scand. 2007;85(5):551–6.PubMedGoogle Scholar
  450. 450.
    Stefanyszyn MA, et al. Lacrimal sac tumors. Ophthal Plast Reconstr Surg. 1994;10(3):169–84.PubMedGoogle Scholar
  451. 451.
    Brar ST, Meyer D. Diagnosis and management of mucoepidermoid carcinoma of the lacrimal duct. Orbit. 2011;30(1):34–6.PubMedGoogle Scholar
  452. 452.
    Brannan PA, et al. A case of primary adenocarcinoma of the lacrimal sac. Orbit. 2005;24(4):291–3.PubMedGoogle Scholar
  453. 453.
    Baredes S, et al. Adenocarcinoma ex-pleomorphic adenoma of the lacrimal sac and nasolacrimal duct: a case report. Laryngoscope. 2003;113(6):940–2.PubMedGoogle Scholar
  454. 454.
    De Stefani A, et al. Squamous cell carcinoma of the lacrimal drainage system: case report and literature review. Tumori. 1998;84(4):506–10.PubMedGoogle Scholar
  455. 455.
    Kuwabara H, Takeda J. Malignant melanoma of the lacrimal sac with surrounding melanosis. Arch Pathol Lab Med. 1997;121(5):517–9.PubMedGoogle Scholar
  456. 456.
    Li YJ, et al. Primary malignant melanoma of the lacrimal sac. BMJ Case Rep. 2012;2012:bcr006349.Google Scholar
  457. 457.
    Woo KI, Suh YL, Kim YD. Solitary fibrous tumor of the lacrimal sac. Ophthal Plast Reconstr Surg. 1999;15(6):450–3.PubMedGoogle Scholar
  458. 458.
    Charles NC, Palu RN, Jagirdar JS. Hemangiopericytoma of the lacrimal sac. Arch Ophthalmol. 1998;116(12):1677–80.PubMedGoogle Scholar
  459. 459.
    Bajaj MS, et al. Neurofibroma of the lacrimal sac. Orbit. 2002;21(3):205–8.PubMedGoogle Scholar
  460. 460.
    Karcioglu ZA, editor. Orbital tumors diagnosis and treatment. New York: Springer; 2005.Google Scholar
  461. 461.
    Naumann GOH, Holbach LM, Kruse FE, editors. Applied pathology for ophthalmic microsurgeons. Berlin/New York: Springer; 2008.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Robert M. Verdijk
    • 1
    Email author
  • Irene Pecorella
    • 2
  • Cornelia M. Mooy
    • 3
  1. 1.Department of Ophthalmic PathologyErasmus MC UniversityRotterdamThe Netherlands
  2. 2.Department of Experimental MedicineUniversity of Rome “Sapienza”RomeItaly
  3. 3.Laboratory for PathologyDordrechtThe Netherlands

Personalised recommendations